Thromboembolic mask of severe lymphocytic myopericarditis: possibilities of clinical and morphological diagnostics and complex treatment

This report presents a clinical case of a 57-year-old female patient who was admitted for dyspnea, productive cough, reduced left ventricular (LV) systolic function, and who had previously undergone thoracocentesis for significant pleural effusion. This case is a unique combination of lymphocytic myocarditis and massive intracardiac and ileo-caval thrombosis. Morphological verification of the diagnosis, that was necessary prior to the administration of immunosuppressive therapy due to the prothrombogenic effect of glucocorticoids, provided a justification for a basis therapy for myocarditis, which significantly improved the patient’s condition.

1. Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal. 2013;34(33):2636–48. DOI: 10.1093/eurheartj/eht210

2. Frustaci A, Chimenti C. Immunosuppressive Therapy in Myocarditis. Circulation Journal. 2014;79(1):4–7. DOI: 10.1253/circj.CJ-14-1192

3. Blagova O.V., Nedostup A.V., Pavlenko E.V., Sedov V.P., Kogan E.A., Gagarina N.V. et al. Myocardial infarction as typical presentation of noncompaction cardiomyopathy. Russian Journal of Cardiology. 2016;10:80–92. DOI: 10.15829/1560-4071-2016-10-80-92

4. Whitehead NJ, Murch S, Leitch JW, Hackworthy RA. Acute myocarditis with thrombus near left ventricular outflow tract. Echocardiography. 2018;35(4):575–7. DOI: 10.1111/echo.13840

5. Bobbert P, Weikert U, Schmidt-Lucke C, Skurk C, Meyer A, Steffens D et al. Platelet activation and thrombus formation relates to the presence of myocardial inflammation in patients with cardiomyopathy. Journal of Cardiology. 2014;63(5):379–84. DOI: 10.1016/j.jjcc.2013.09.014

6. Alkhouli M, Morad M, Narins CR, Raza F, Bashir R. Inferior Vena Cava Thrombosis. JACC: Cardiovascular Interventions. 2016;9(7):629–43. DOI: 10.1016/j.jcin.2015.12.268

7. Vidal-Perez R, Casas CAJ, Agra-Bermejo RM, Alvarez-Alvarez B, Grapsa J, Fontes-Carvalho R et al. Myocardial infarction with non-obstructive coronary arteries: A comprehensive review and future research directions. World Journal of Cardiology. 2019;11(12):305–15. DOI: 10.4330/wjc.v11.i12.305

8. Blagova O.V., Pavlenko E.V., Varionchik N.V., Nedostup A.V., Sedov V.P., Kogan Е.A. et al. Myocarditis as a legitimate phenomenon in non-compaction myocardium: diagnostics, management and influence on outcomes. Russian Journal of Cardiology. 2018;2:44–52. DOI: 10.15829/1560-4071-2018-2-44-52

9. Paç FA, Çağdaş DN. Treatment of massive cardiac thrombi in a patient with protein C and protein S deficiency. Blood Coagulation & Fibrinolysis. 2007;18(7):699–702. DOI: 10.1097/MBC.0b013e3282eff788

10. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ et al. Myocarditis. A histopathologic definition and classification. The American Journal of Cardiovascular Pathology. 1987;1(1):3–14. PMID: 3455232

11. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1996;93(5):841–2. DOI: 10.1161/01.CIR.93.5.841